News
Orforglipron: What to Know About Eli Lilly’s New Weight Loss Pill for Obesity
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials. The weight loss pill also significantly improved heart health markers like cholesterol and blood pressure.
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Before your next weight loss attempt, uncover the risks of dieting that are rarely discussed by health care providers.
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...
Although new medicines can help you lose weight faster and healthier than ever, a new psychology is needed to keep your ...
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
For most actors, simply learning their lines isn’t enough to do their role justice. Instead, they lean into embodying the ...
Fitness trainer Julie took to her Instagram account to share 5 ChatGPT prompts to help you create a calorie deficit diet, a personalised meal plan, a workout schedule, and more. She shared how these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback